Literature DB >> 11976409

Lymphatic metastasis in the absence of functional intratumor lymphatics.

Timothy P Padera1, Ananth Kadambi, Emmanuelle di Tomaso, Carla Mouta Carreira, Edward B Brown, Yves Boucher, Noah C Choi, Douglas Mathisen, John Wain, Eugene J Mark, Lance L Munn, Rakesh K Jain.   

Abstract

Lymphatic metastasis contributes to mortality from solid tumors. Whether metastasizing cancer cells reach lymph nodes via intratumor lymphatic vessels is unknown. Here, we examine functional lymphatics associated with mouse tumors expressing normal or elevated levels of vascular endothelial growth factor-C (VEGF-C), a molecule that stimulates lymphangiogenesis. Although VEGF-C overexpression increased lymphatic surface area in the tumor margin and lymphatic metastasis, these tumors contained no functional lymphatics, as assessed by four independent functional assays and immunohistochemical staining. These findings suggest that the functional lymphatics in the tumor margin alone are sufficient for lymphatic metastasis and should be targeted therapeutically.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11976409     DOI: 10.1126/science.1071420

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  281 in total

1.  Lymphatic microvessel density as a prognostic factor in non-small cell lung carcinoma: a meta-analysis of the literature.

Authors:  Jun Wang; Kainan Li; Baocheng Wang; Jingwang Bi
Journal:  Mol Biol Rep       Date:  2011-12-14       Impact factor: 2.316

Review 2.  Action and reaction: the biological response to siRNA and its delivery vehicles.

Authors:  Rosemary L Kanasty; Kathryn A Whitehead; Arturo J Vegas; Daniel G Anderson
Journal:  Mol Ther       Date:  2012-01-17       Impact factor: 11.454

3.  In vivo imaging of lymphatic vessels in development, wound healing, inflammation, and tumor metastasis.

Authors:  Inés Martínez-Corral; David Olmeda; Rodrigo Diéguez-Hurtado; Tuomas Tammela; Kari Alitalo; Sagrario Ortega
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-02       Impact factor: 11.205

4.  Clinicopathological predictors of lymphatic metastasis in HNSCC: implications for molecular mechanisms of metastatic disease.

Authors:  Tovë M Goldson; Yimei Han; Kristen B Knight; Heidi L Weiss; Vicente A Resto
Journal:  J Exp Ther Oncol       Date:  2010

Review 5.  Nanomedicinal strategies to treat multidrug-resistant tumors: current progress.

Authors:  Xiaowei Dong; Russell J Mumper
Journal:  Nanomedicine (Lond)       Date:  2010-06       Impact factor: 5.307

Review 6.  Current views on the function of the lymphatic vasculature in health and disease.

Authors:  Yingdi Wang; Guillermo Oliver
Journal:  Genes Dev       Date:  2010-10-01       Impact factor: 11.361

Review 7.  Nanoparticle delivery systems for cancer therapy: advances in clinical and preclinical research.

Authors:  Susana Patricia Egusquiaguirre; Manuela Igartua; Rosa María Hernández; José Luis Pedraz
Journal:  Clin Transl Oncol       Date:  2012-02       Impact factor: 3.405

8.  Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma.

Authors:  Eiji Kikuchi; Vitaly Margulis; Pierre I Karakiewicz; Marco Roscigno; Shuji Mikami; Yair Lotan; Mesut Remzi; Christian Bolenz; Cord Langner; Alon Weizer; Francesco Montorsi; Karim Bensalah; Theresa M Koppie; Mario I Fernández; Jay D Raman; Wassim Kassouf; Christopher G Wood; Nazareno Suardi; Mototsugu Oya; Shahrokh F Shariat
Journal:  J Clin Oncol       Date:  2008-12-15       Impact factor: 44.544

9.  Adrenomedullin gene dosage correlates with tumor and lymph node lymphangiogenesis.

Authors:  Natalie O Karpinich; Daniel O Kechele; Scott T Espenschied; Helen H Willcockson; Yuri Fedoriw; Kathleen M Caron
Journal:  FASEB J       Date:  2012-10-25       Impact factor: 5.191

10.  Optical tracer size differences allow quantitation of active pumping rate versus Stokes-Einstein diffusion in lymphatic transport.

Authors:  Alisha V DSouza; Kayla Marra; Jason R Gunn; Kimberley S Samkoe; Brian W Pogue
Journal:  J Biomed Opt       Date:  2016-10-01       Impact factor: 3.170

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.